DocuSign Inc. logo

DocuSign Inc. (DOCU)

Market Closed
5 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
92. 90
-0.94
-1%
$
18.55B Market Cap
252.44 P/E Ratio
0% Div Yield
4,650,408 Volume
1.92 Eps
$ 93.84
Previous Close
Day Range
92.36 94.67
Year Range
48.7 107.86

Summary

DOCU closed today lower at $92.9, a decrease of 1% from yesterday's close, completing a monthly increase of 12.74% or $10.5. Over the past 12 months, DOCU stock gained 2.63%.
DOCU is not paying dividends to its shareholders.
The last earnings report, released on Jun 04, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.01%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 10 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).
Want to track DOCU and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

DOCU Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.
DocuSign Q1: Lowered Billing Growth Is Just Renewal Timing Issue

DocuSign Q1: Lowered Billing Growth Is Just Renewal Timing Issue

I reiterate my 'Buy' rating on DocuSign, with a fair value estimate of $95 per share, despite near-term billing growth deceleration. DocuSign's international expansion and growing Intelligent Agreement Management platform are key drivers for sustained high-single-digit revenue growth. Recent go-to-market changes led to lower renewal billings, but I see this as a timing issue, not a demand problem.

Seekingalpha | 3 hours ago
DocuSign (DOCU) Reports Q1 Earnings: What Key Metrics Have to Say

DocuSign (DOCU) Reports Q1 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for DocuSign (DOCU) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 9 hours ago
DocuSign (DOCU) Surpasses Q1 Earnings and Revenue Estimates

DocuSign (DOCU) Surpasses Q1 Earnings and Revenue Estimates

DocuSign (DOCU) came out with quarterly earnings of $0.90 per share, beating the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.82 per share a year ago.

Zacks | 9 hours ago

DocuSign Inc. Dividends

DOCU is not paying dividends to its shareholders.

DocuSign Inc. Earnings

4 Jun 2025 Date
-
Cons. EPS
-
EPS
5 Mar 2025 Date
0.85
Cons. EPS
0.86
EPS
5 Dec 2024 Date
0.87
Cons. EPS
0.9
EPS
5 Sep 2024 Date
0.8
Cons. EPS
0.97
EPS
6 Jun 2024 Date
0.79
Cons. EPS
0.82
EPS
DOCU is not paying dividends to its shareholders.
4 Jun 2025 Date
-
Cons. EPS
-
EPS
5 Mar 2025 Date
0.85
Cons. EPS
0.86
EPS
5 Dec 2024 Date
0.87
Cons. EPS
0.9
EPS
5 Sep 2024 Date
0.8
Cons. EPS
0.97
EPS
6 Jun 2024 Date
0.79
Cons. EPS
0.82
EPS

DocuSign Inc. (DOCU) FAQ

What is the stock price today?

The current price is $92.90.

On which exchange is it traded?

DocuSign Inc. is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is DOCU.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 18.55B.

Has DocuSign Inc. ever had a stock split?

No, there has never been a stock split.

DocuSign Inc. Profile

Software - Application Industry
Technology Sector
Mr. Allan C. Thygesen CEO
NASDAQ (NGS) Exchange
256163106 Cusip
US Country
6,838 Employees
- Last Dividend
- Last Split
27 Apr 2018 IPO Date

Overview

DocuSign, Inc. is a pioneering company known for its electronic signature solution, operating both in the United States and internationally. Founded in 2003 and headquartered in San Francisco, California, DocuSign has effectively revolutionized the way agreements are sent and signed across the globe. By integrating its services across various devices, and catering to a broad spectrum of compliance needs, including those of U.S. federal government agencies and life sciences, the company has positioned itself as a key player in digital transaction management. DocuSign sells its innovative products through a combination of direct sales, partner-assisted sales, and digital self-service purchasing methods, showcasing its versatility and commitment to customer convenience and security.

Products and Services

  • E-signature Solution - Enables the electronic sending and signing of agreements on various devices, making transactions more efficient and secure.
  • Contract Lifecycle Management (CLM) - Automates workflows throughout the entire agreement process, enhancing operational efficiency and reducing manual work.
  • Document Generation - Simplifies the creation of custom agreements, streamlining document preparation and saving time.
  • Gen for Salesforce - Allows for the automatic generation of agreements within Salesforce with a few clicks, integrating sales and agreement processes seamlessly.
  • Identify - A signer-identification option providing an extra layer of security by checking government-issued IDs.
  • Standards-Based Signatures - Supports digital signatures that involve digital certificates, catering to specific legal and regulatory requirements.
  • Monitor - Utilizes advanced analytics to track the usage of DocuSign eSignature web, mobile, and API account, enhancing oversight and management.
  • Notary - Enables notaries public to conduct remote online notarization transactions, broadening the scope of digital agreements.
  • Web Forms - Creates web forms to quickly draft agreements using data from completed forms or external systems via APIs, increasing efficiency.
  • Rooms for Real Estate - Offers a digital platform for brokers and agents to manage the entire real estate transaction process, from start to finish.
  • FedRAMP Authorized eSignature - An authorized version of DocuSign eSignature for U.S. federal government agencies, ensuring compliance with strict security standards.
  • Life Sciences Modules - Supports compliance with the electronic signature practices in the life sciences industry, addressing sector-specific regulatory requirements.

Contact Information

Address: 221 Main Street
Phone: 415 489 4940